Sir,
Bilateral diabetic papillopathy associated with optic disc neovascularisation Diabetic papillopathy is an uncommon condition characterised by transient visual dysfunction associated with optic disc swelling of otherwise unexplained aetiology. I It usually occurs in the context of background diabetic retinopathy? We report a case of diabetic papillopathy associated with optic disc neovascularisation.
Case report
A 17-year-old Caucasian female with type 1 diabetes since 8 years of age was admitted to hospital with a 4 month history of blurred vision, and a 1 month history of transient visual obscurations, nausea, lethargy and mild weight loss. She denied headache or other neurological symptoms. She had a several-year history of poor diabetic control and episodes of diabetic ketoacidosis. However, significant improvement had occurred over recent months as indicated by HbA l e levels of 6.3% on admission compared with 13.9% 4 months previously.
On examination she was orientated, apyrexial and normotensive. General examination was normal. Corrected visual acuities were 6/12 in each eye. She had no relative afferent defect, the anterior segments were normal and the intraocular pressures were 14 mmHg in each eye. Fundoscopy showed bilateral florid disc neovascularisation associated with gross disc swelling and signs of widespread retinal ischaemia. Goldmann visual fields were normal. A full blood count, urea, electrolytes, vasculitis screen, liver and thyroid function tests, clotting screen, ESR, amylase, synacthen test, chest radiotherapy, brain CT scan and lumbar puncture (CSF pressure, microscopy, cytology and culture) revealed no abnormality.
She underwent fractionated panretinal photocoagulation (PRP), receiving approximately 1600 burns to each eye. One month later, her visual acuities had improved to 6/6 in each eye, the disc swelling had partially resolved, but the optic disc new vessels persisted. These findings were confirmed by fluorescein angiography (Fig. 1) , and a further 1600 PRP burns were applied. Three months later, visual acuities were 6/5 in each eye, and there was no evidence of disc neovascularisation or disc swelling. Her diabetes control remained good during the treatment period with fructosamine levels ranging from 237 to 284 I-Lmol/l.
Comment
Diabetic papillopathy was described in 1971 in three teenaged patients with type 1 diabetes mellitus. I Subsequent reports of the phenomenon in small case series3--{; and a larger retrospective studr have increased our understanding of this uncommon clinical entity.
Diabetic papillopathy can occur in type 1 and type 2 diabetics. It is more commonly bilateral than unilateral. Visual acuity is usually mildly to moderately reduced 
Retinal new vessels are a recognised, if uncommon, clinical finding in patients with diabetic papillopathy, 2 ,4-6 and non-perfusion has been demonstrated in up to 50% of patients using fluorescein angiography? However, associated disc neovascularisation is rare: to our knowledge it has been reported in only three patients, occurring several weeks after the observation of diabetic papillopathy in each case?,7 Our patient was unusual in presenting with signs of diabetic papillopathy and disc new vessels concurrently. In her case, the disc new vessels were clearly visible on slit-lamp biomicroscopy and were highlighted by the fluorescein angiography as shown in Fig. 1 . However, in cases of less florid neovascularisation, distinction from the surface telangiectatic vessels characteristic of diabetic papillopathy may be more difficult and requires careful observation of the disc vessel pattern. New vessels of ischaemic origin tend to be more randomly orientated and elevated above the plane of the retina and disc, whereas the fine telangiectatic vessels of diabetic papillopathy are more radially orientated and lie within the disc and retina. Fluorescein angiography tends not to be helpful because profuse leakage from the disc vessels can occur in both conditions. 3 From a management standpoint, diabetic papillopathy should be a diagnosis of exclusion, following investigation of other causes of swollen discs. This report highlights the importance of careful funduscopy to identify coexisting severe diabetic retinopathy and, in particular, optic disc neovascularisation.
Sir,
Severe hypotony following cataract extraction in a patient on latanoprost Latanoprost is a topical ocular hypotensive medication (prostaglandin F 2 o: analogue) which works via the uveoscleral pathway.l To the best of our knowledge, choroidal detachment caused by latanoprost in a glaucoma patient following cataract surgery has not been described. We report the following case to illustrate a potential side-effect of latanoprost.
Case re p ort He underwent an uneventful right phacoemulsification with posterior implant under local anaesthetic in November 1999. The pre-operative visual acuity was 6/9 in the right eye with an lOP of 16 mmHg. His immediate post-operative period was unremarkable, with a visual acuity of 6/9 and an lOP of 16 mmHg on latanoprost and bethamethasone at 1 week. He presented 6 weeks post-operatively with a painful right eye. Examination revealed a visual acuity of 6/24 in the right eye and an lOP of 0 mmHg. The Seidel test was negative. The anterior chamber was deep and quiet. Fundal examination showed a large choroidal detachment in the supranasal and supratemporal areas. Latanoprost was discontinued and prednisolone 0.5% 4 times a day was started in the right eye. Four weeks later, the visual acuity in the right eye recovered to 6/9 with an lOP of 19 mmHg, and a complete resolution of choroidal effusion. At 3 months follow-up his lOP in the right eye remained controlled at 12 mmHg without treatment.
Comment
Our case illustrates a patient with poorly controlled glaucoma whose lOP stabilised on latanoprost treatment but who later developed profound hypotony following cataract extraction.
The pressure-lowering effect of phacoemulsification has been described in a number of studies, typically in the range of 1.1-2.5 mmHg. 2 In another study, the pressure-lowering effect of phacoemulsification in glaucoma patients was not effective until a year later. 3 The mechanism by which phacoemulsification lowers lOP is unclear, but it is thought to be related to the
